Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child-Pugh grade correlated with prognosis after transarterial chemoembolization

Japanese Journal of Radiology

Volumn 32, Issue 5, 2014, Pages 260-265

  Yamakado, Koichiro ^a   Miyayama, Shiro ^b   Hirota, Shozo ^c   Mizunuma, Kimiyoshi ^d   Nakamura, Kenji ^e   Inaba, Yoshitaka ^f   Maeda, Hiroaki ^c   Matsuo, Kunihiro ^g   Nishida, Norifumi ^h   Aramaki, Takeshi ⁱ   Anai, Hiroshi ^j   Koura, Shinichi ^k   Oikawa, Shigeo ^l   Watanabe, Ken ^m   Yasumoto, Taku ⁿ   Furuichi, Kinya ^o   Yamaguchi, Masato ^p  

^a MIE UNIVERSITY   (Japan)

^b FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d NASU RED CROSS HOSPITAL   (Japan)

^e Daito Central Hospital   (Japan)

^f AICHI CANCER CENTER HOSPITAL   (Japan)

^g Narumi Hospital   (Japan)

^h Osaka Prefecture University   (Japan)

ⁱ SHIZUOKA CANCER CENTER   (Japan)

^j NARA MEDICAL UNIVERSITY   (Japan)

^k FUKUOKA UNIVERSITY   (Japan)

^l Iwate Prefectural Central Hospital   (Japan)

^m JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^o Higashiosaka City General Hospital   (Japan)

^p KOBE UNIVERSITY   (Japan)

more..

Author keywords

Arterial embolization; Child Pugh grade; Hepatocellular carcinoma; Prognosis; Tumor diameter; Tumor number

Indexed keywords

EPIRUBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHEMOEMBOLIZATION; CHILD PUGH SCORE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RUPTURE; TUMOR RUPTURE; CANCER GRADING; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84901687584     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-014-0298-9     Document Type: Article

References (10)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-17. (Pubitemid 37518510)
2. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J Hepatol. 2012;56(Suppl 1):S75-87.
3. Cammà C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224:47-54. (Pubitemid 34680374)
4. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429-42. (Pubitemid 36152543)
5. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet. 2002;359:1734-9. (Pubitemid 34607087)
6. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164-71. (Pubitemid 34454013)
7. Yamakado K, Miyayama S, Hirota S, Mizunuma K, Nakamura K, Inaba Y, et al. Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis? Jpn J Radiol. 2012;30(7):560-6.
8. Bruix J, Sherman M. Practice guidelines committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-36.
9. Bolondi L, Burroughs A, Dufour JF, Galle PR, Mazzaferro V, Piscaglia F, et al. Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis. 2012; 32(4):348-59.
10. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35-43.